Long‐Term Outcome Following Successful Pulmonary Vein Isolation: Pattern and Prediction of Very Late Recurrence
- 25 July 2008
- journal article
- clinical trial
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 19 (7) , 661-667
- https://doi.org/10.1111/j.1540-8167.2008.01101.x
Abstract
Background: Despite encouraging results of pulmonary vein isolation (PVI) ablation for atrial fibrillation (AF), it is unclear whether there is genuine cure or there is an important attrition rate. We sought to determine the long‐term outcome of the initial responders who experienced a prolonged AF‐free complete response. Methods: From a series of 350 consecutive patients who underwent PVI for AF, 264 patients (75%) (males 71%, age 57 ± 12 years, paroxysmal AF 87%) who demonstrated ≥1 year AF‐free follow‐up on no antiarrhythmic drugs were followed for 1–5 years. Results: During 28 ± 12 months follow‐up, 23 of 264 (8.7%) patients had recurrence of AF. The actuarial recurrence at 2 years postablation was 5.8% and increased to 25.5% at 5 years. Compared with long‐term responders, more patients with late recurrence had hypertension (HR = 2.18, P = 0.009) and hyperlipidemia (HR = 4.01, P = 0.0005). Among 18 patients with recurrent AF necessitating repeat PVI, 15 (83%) required re‐isolation of > 1 PV and 28 of 45 (58%) PVs showed reconnection. All PVs were re‐isolated and five (28%) patients had additional linear ablation. All 15 patients became AF‐free again. Conclusions: Although most patients following PVI remain AF‐free, some patients develop “late” recurrence of AF. The “late” recurrence patients are more likely to have hypertension and hyperlipidemia. Most late recurrences are associated with PV reconnections. Our observations emphasize the importance of continued long‐term vigilance for AF recurrence, and also raise concerns regarding the need for long‐term anticoagulation therapy.Keywords
This publication has 27 references indexed in Scilit:
- Impact of Heart Rhythm Status on Registration Accuracy of the Left Atrium for Catheter Ablation of Atrial FibrillationJournal of Cardiovascular Electrophysiology, 2007
- Non‐Antiarrhythmic Drugs in Atrial Fibrillation: A Review of Non‐Antiarrhythmic Agents in Prevention of Atrial FibrillationJournal of Cardiovascular Electrophysiology, 2007
- The Effects of Statins and Renin‐Angiotensin System Blockers on Atrial Fibrillation Recurrence Following Antral Pulmonary Vein IsolationJournal of Cardiovascular Electrophysiology, 2007
- Incidence and Predictors of Very Late Recurrence of Atrial Fibrillation After AblationJournal of Cardiovascular Electrophysiology, 2006
- Lipid-lowering drugs: Beyond lowering lipid levels to their influence on cardiac arrhythmiasHeart Rhythm, 2006
- Prevalence, Treatment, and Control of Combined Hypertension and Hypercholesterolemia in the United StatesThe American Journal of Cardiology, 2006
- Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunctionPublished by Elsevier ,2006
- Anatomic substrate, procedural results, and clinical outcome of ultrasound-guided left atrial–pulmonary vein disconnection for treatment of atrial fibrillationThe American Journal of Cardiology, 2005
- Angiotensin-converting enzyme inhibitors: a new therapy for atrial fibrillation?American Heart Journal, 2004
- Incidence and Location of Focal Atrial Fibrillation Triggers in Patients Undergoing Repeat Pulmonary Vein Isolation:Journal of Cardiovascular Electrophysiology, 2003